More recently, myeloid-derived osteopontin (encoded by SPP1) was shown to trigger a chronic activation of NFAT2 in tumor-reactive CD8+ T cells, leading to T cell dysfunction and exhaustion in an experimental mouse model of GBM (Kilian et al., 2023). Here, CD8A is linked to neoplasm.